Claim this
Startup
Write to the

BHV Pharma

http://www.bhvpharma.com
Pharmaceuticals

About BHV Pharma

BHV Pharma is developing a novel, best in class, Sodium Glucose Transporter 2 (SGLT2) inhibitor indicated for Type 2 Diabetes and NASH. Remogliflozin has been dosed in over 800 subjects in over 20 cli...

BHV Pharma describes itself with 3 words or categories

PharmaceuticalsBiotechnologyDiabetes

Video

Presentation

More Detail

BHV Pharma is a clinical stage pharmaceutical company focused on developing therapeutics to improve the lives of patients with metabolic disorders including diabetes, obesity, and NASH. The Company's ...

Case Study

Competitive Landscape

Capitalization

  • #DATA_YEAR# : $
    #NAME#
    from #DATA_FROM#
  • News

    No news added yet.

    Location

    Headquarters

    Company Size

    1-10 employees

    Type

    Privately Held

    Founded

    2009